Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors

  • Federica Sorà, Francesca Romana Ponziani, Luca Laurenti, Patrizia Chiusolo, Francesco Autore, Antonio Gasbarrini, Simona Sica, Maurizio Pompili
  • Leukemia & Lymphoma, August 2016, Taylor & Francis
  • DOI: 10.1080/10428194.2016.1219906

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/10428194.2016.1219906